Emperipolesis in a patient receiving romiplostim

Am J Hematol. 2016 Jan;91(1):166. doi: 10.1002/ajh.24199. Epub 2015 Nov 17.

Authors

Nichola Cooper¹, Barbara J Bain²

Affiliations

¹ Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, W12 0HS, United Kingdom.
² Faculty of Medicine, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, W2 1NY, United Kingdom.

PMID: 26407183
DOI: 10.1002/ajh.24199

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Blood Platelets / cytology
Dose-Response Relationship, Drug
Emperipolesis / drug effects*
Humans
Male
Megakaryocytes / cytology
Platelet Count
Purpura, Thrombocytopenic, Idiopathic / blood*
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Receptors, Fc / administration & dosage
Receptors, Fc / therapeutic use
Recombinant Fusion Proteins / administration & dosage
Recombinant Fusion Proteins / adverse effects*
Recombinant Fusion Proteins / therapeutic use
Thrombopoietin / administration & dosage
Thrombopoietin / adverse effects*
Thrombopoietin / therapeutic use

Substances

Receptors, Fc
Recombinant Fusion Proteins
Thrombopoietin
romiplostim